No More Tension Of Weight -Buy Acomplia

Sanofi-Synthelabo, a French Pharmaceutical Company created Rimonabant (Acomplia and possibly Zimulti) which is a new drug treatment for obesity and possibly other ailments. This diet pill was officially approved in Britain on June 28th 2006. It is expected to be approved in other European countries this year including Germany, Finland, Norway, Ireland, Denmark. Which could lead the way to having the FDA approve it for the United States. But no guarantees, The FDA has strick policies regarding new medications on the market.

Acomplia (Rimonabant or Zimulti) diet pills offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle. This medication (as any) obviously does not come without some potential side effects for its user but could offer more that others. Rimonabant works differently than other weightloss pills, and has other potential benefits than any other diet drug. Studies also show that it increases levels of HDL (good cholesterol) while at the same time reducing the triglycerides (bad cholesterol). It could also possibly be used as a smoking cessation although not officially approved as one (yet).

Basically put, Rimonabant suppresses the ones appetite. It works by blocking a cellular receptor in the endocannabinoid system of the brain, believed to influence the regulation of body weight, glucose and lipid metabolism. In doing so it is believed that this regulation then reduces the craving to eat more.

Clinical Studies have shown that 33% of people taking Rimonabant lost 10% of body weight and kept their weight down for two years which is extremely newsworthy as no other diet drug has accomplished this for so long a period. It also holds huge potential for the obese individual who also wants to kick the smoking habit apparently also help out in cocaine, marijuana and alcohol additions.

Source:-www.rimonabant-health.com